ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,147.81
-0.98%
Dow Jones
38,747.42
-0.31%
Gold vs US Dollar
2,313.985
-0.05%
Brent Oil
82.08
0.10%
Bitcoin
67,557.00
0.34%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Structure Therapeutics Inc (GPCR)

  7. Structure Therapeutics Inc (GPCR) News

Structure Therapeutics (GPCR)

Structure Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GPCR
DateTimeSourceHeadlineSymbolCompany
07/06/202421:05GlobeNewswire Inc.Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary SharesNASDAQ:GPCRStructure Therapeutics Inc
06/06/202421:17Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:GPCRStructure Therapeutics Inc
06/06/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GPCRStructure Therapeutics Inc
06/06/202400:53GlobeNewswire Inc.Structure Therapeutics Announces Pricing of Upsized $476 Million Public OfferingNASDAQ:GPCRStructure Therapeutics Inc
06/06/202400:43Edgar (US Regulatory)Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]NASDAQ:GPCRStructure Therapeutics Inc
06/06/202400:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GPCRStructure Therapeutics Inc
03/06/202421:59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
03/06/202421:58Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GPCRStructure Therapeutics Inc
03/06/202421:09GlobeNewswire Inc.Structure Therapeutics Announces Proposed Public Offering of American Depositary Shares and Pre-Funded WarrantsNASDAQ:GPCRStructure Therapeutics Inc
03/06/202421:02Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:GPCRStructure Therapeutics Inc
03/06/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
03/06/202412:30GlobeNewswire Inc.Structure Therapeutics Reports Positive Topline Data from its Phase 2a Obesity Study and Capsule to Tablet PK Study for its Oral Non-Peptide Small Molecule GLP-1 Receptor Agonist GSBR-1290NASDAQ:GPCRStructure Therapeutics Inc
09/05/202421:56Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GPCRStructure Therapeutics Inc
09/05/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
09/05/202421:05GlobeNewswire Inc.Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent HighlightsNASDAQ:GPCRStructure Therapeutics Inc
08/03/202421:19Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:GPCRStructure Therapeutics Inc
08/03/202421:05GlobeNewswire Inc.Structure Therapeutics to Present at Leerink Partners Global Biopharma ConferenceNASDAQ:GPCRStructure Therapeutics Inc
08/03/202414:19Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:GPCRStructure Therapeutics Inc
08/03/202413:43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
08/03/202413:30GlobeNewswire Inc.Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent HighlightsNASDAQ:GPCRStructure Therapeutics Inc
18/12/202313:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
18/12/202312:30GlobeNewswire Inc.Structure Therapeutics Provides Comprehensive GSBR-1290 Program Update Including Clinically Meaningful Proof-of-Concept Data From Phase 2a Clinical StudyNASDAQ:GPCRStructure Therapeutics Inc
30/11/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GPCRStructure Therapeutics Inc
17/11/202322:25Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:GPCRStructure Therapeutics Inc
17/11/202321:55Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GPCRStructure Therapeutics Inc
17/11/202321:51Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:GPCRStructure Therapeutics Inc
16/11/202322:13Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:GPCRStructure Therapeutics Inc
14/11/202321:10GlobeNewswire Inc.Structure Therapeutics Reports Third Quarter 2023 Financial Results and Recent HighlightsNASDAQ:GPCRStructure Therapeutics Inc
29/09/202312:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
29/09/202312:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:GPCR

Your Recent History

UNSW
LIENETH
lien
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved